AAO 2024: Ovarian Cancer Drug Mirvetuximab Linked to Corneal Toxicity
The toxicity led to decreased visual acuity, but resolved with dose modifications or steroid eye drops
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.